Published in Anti-Infectives Week, October 31st, 2005
According to recent research from Bulgaria, "In the present study the effect of the indole alkaloid ibogaine on the in vitro lipolytic activity and adherence to epithelial cells of Candida albicans was investigated.
"The substance was administered intraperitoneally at a dose of 5 mg kg-1 day(-1) in mice with disseminated and gastrointestinal C. albicans infections."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.